Evidence map›Paper›PMID 39816648›Full record

ArticleFrontiers in antibiotics2023

A comparison of various feature extraction and machine learning methods for antimicrobial resistance prediction in

Deniz Ece Kaya, Ege Ülgen, Ayşe Sesin Kocagöz, Osman Uğur Sezerman

Abstract read
In one paragraph

Article in Frontiers in antibiotics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Predicting clinical outcome ofMicrobial genomics · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Deniz Ece KayaDepartment of Biostatistics and Medical Informatics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Ege ÜlgenDepartment of Biostatistics and Medical Informatics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Ayşe Sesin KocagözDepartment of Infectious Diseases, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Osman Uğur SezermanDepartment of Biostatistics and Medical Informatics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae is one of the major concerns of clinicians and one of the global public health problems. This pathogen is associated with high morbidity and mortality rates and antimicrobial resistance (AMR). In the last few years, reduced genome sequencing costs have made it possible to explore more of the drug resistance of S. pneumoniae, and machine learning (ML) has become a popular tool for understanding, diagnosing, treating, and predicting these phenotypes. Nucleotide k-mers, amino acid k-mers, single nucleotide polymorphisms (SNPs), and combinations of these features have rich genetic information in whole-genome sequencing. This study compares different ML models for predicting AMR phenotype for S. pneumoniae. We compared nucleotide k-mers, amino acid k-mers, SNPs, and their combinations to predict AMR in S. pneumoniae for three antibiotics: Penicillin, Erythromycin, and Tetracycline. 980 pneumococcal strains were downloaded from the European Nucleotide Archive (ENA). Furthermore, we used and compared several machine learning methods to train the models, including random forests, support vector machines, stochastic gradient boosting, and extreme gradient boosting. In this study, we found that key features of the AMR prediction model setup and the choice of machine learning method affected the results. The approach can be applied here to further studies to improve AMR prediction accuracy and efficiency.

Indexed as

AMRkmermachine learningSNPstreptococcus pneumonaiewhole genome sequencing (WGS)

Identifiers

PMID39816648
PMCPMC11731958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.